Kyntra Bio (KYNB) Price to FCF (2014 - 2026)
Kyntra Bio's (KYNB) quarterly Price to FCF came in at 7.66 in Q2 2026, down 552.76% year-over-year from 1.69 in Q2 2025, and down 287.57% quarter-over-quarter from 1.98 in Q1 2026.
Analysis
Kyntra Bio (KYNB) Price to FCF (2014 - 2026) Analysis & Trends
Kyntra Bio has disclosed Price to FCF across 13 years of filings, most recently posting 7.66 for Q2 2026.
- In Q2 2026, Price to FCF fell 552.76% year-over-year to 7.66; the TTM figure through Jun 2026 stood at 0.8 (up 11.22% YoY), while the FY2025 annual figure was 7.38, down 1810.59% from the prior year.
- Price to FCF came in at 7.66 for Q2 2026 at Kyntra Bio, down from 1.98 in the prior quarter.
- In the past five years, Price to FCF ranged from a high of 11.59 in Q1 2025 to a low of 110.87 in Q1 2022.
- Average Price to FCF over 5 years is 14.17, with a median of 4.33 recorded in 2023.
- Year-over-year, Price to FCF jumped 393.98% in 2025 and plunged 552.76% in 2026.
- Over 5 years, Price to FCF stood at 28.55 in 2022, then surged by 83.49% to 4.71 in 2023, then jumped by 62.96% to 1.75 in 2024, then retreated by 11.04% to 1.94 in 2025, then tumbled by 295.09% to 7.66 in 2026.
- Per Business Quant data, the three most recent Price to FCF figures were 7.66 in Q2 2026, 1.98 in Q1 2026, and 1.94 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Kyntra Bio | 32.30 Mn | 32.30 Mn | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.66 |
| Mar 31, 2026 | -1.98 |
| Dec 31, 2025 | -1.94 |
| Sep 30, 2025 | -26.70 |
| Jun 30, 2025 | 1.69 |
| Mar 31, 2025 | 11.59 |
| Dec 31, 2024 | -1.75 |
| Sep 30, 2024 | -4.76 |
| Jun 30, 2024 | -2.25 |
| Mar 31, 2024 | -3.94 |
| Dec 31, 2023 | -4.71 |
| Sep 30, 2023 | -1.00 |
| Jun 30, 2023 | -2.38 |
| Mar 31, 2023 | -17.64 |
| Dec 31, 2022 | -28.55 |
| Sep 30, 2022 | -23.17 |
| Jun 30, 2022 | -29.14 |
| Mar 31, 2022 | -110.87 |
| Dec 31, 2021 | -23.24 |
| Sep 30, 2021 | 22.20 |